Skip to content
MedGenome – Leading Genetics Diagnostics Lab in India
MedGenome – Leading Genetics Diagnostics Lab in India
Menu
About Us
Tests & Services
Claria
Non-invasive prenatal screening test (NIPT)
Carrier Screening
PGT-A/PGT-M, S
Recurrent Pregnancy Loss Test
Rhesus D Track
Molecular Cytogenetics
Maternal Serum Screening
More...
Actia
ExomeMAX
Whole Exome
Rapid Exome Analysis
Trio Exome
Clinical Exome
Chromosomal Microarray
Neuro Genetics
FSHD1
Nephro Genetics
Metabolic Genetics
Cardio Genetics
Endocrine Genetics
Ocular Genetics
ENT Genetics
Polygenic Risk Score for CAD
More...
Prima
Liquid Biopsy
TumorTrack Advance
Thyrotrack
LungTrack Advance
BRCA1 and BRCA2 Gene Test
HLA Typing
Tumor Mutation Burden
Molecular testing for Solid Tumors
Molecular testing for Hematological Malignancies
clonoSEQ® NGS MRD
Thalassemia Mutation Testing
Immunophenotyping by Flowcytometry
More...
Micra
SPIT SEQ
TB Diagnostics Solution
Gastrointestinal Infections
SES for CNS Infections
SES for Systemic Infections
SES for Eye Infections
COVID-19 (SARS-CoV2) RT-PCR Test
More...
Immucare
RESEARCH SERVICES
Resources
Blog
Brochures
Publications
Press/Media
Patient Stories
Videos
Insights
Coronary Artery Disease
BRCA1 and BRCA2
NIPT
Genetic Counseling
Rare Diseases
HLA Typing
Genetic Insights
DNA Insights
Request Test Details
Schedule Genetic Counselling
Choose the region
Region:
MedGenome Labs unveils FSHD1 genetic screening test for rare disease diagnosis
Related Articles
A genetic testing revolution is on. Indian patients lining up for answers to rare diseases
MedGenome appoints Martin Dewhurst as Chairman of Advisory Board
Winter Heart Attack Prevention Tips: 7 Lifestyle Modifications To Keep Your Heart Healthy
Genetic Testing: Know your risk of hereditary cancer
Toll free number: 1800 103 3691
diagnostics@medgenome.com
Enquire Now
Call Now